Novozymes A/S 2024 Outlook and 2023 Pro Forma Financials Call Transcript

Mar 21, 2024 / 08:00AM GMT
Operator

Welcome to the Novonesis conference call regarding pro forma financials and outlook. (Operator Instructions).

Today, I'm pleased to leave the word to Tobias Cornelius Bjorklund, Head of Investor Relations. Please begin your meeting.

Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR

Outlook and pro forma financials for Novonesis. My name is Tobias Bjorklund and I'm Head of Investor Relations here at Novonesis. During the call, our CEO, Ester Baiget and our CFO, Rainer Lehmann, will provide commentary on the announced outlook for '24 and go through the highlights of the pro forma financials for 2023.

Attending today's call, we also have Jacob Paulsen, EVP of Food & Beverage Biosolutions; Amy Byrick, EVP of Human Health Biosolutions; and Tina Fano, EVP of Planetary Health Biosolutions. The conference call is set to take 45 minutes, including Q&A, and the presentation by management will take around 10, 15 minutes, leaving ample room for questions.

I would like to remind you that the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot